Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults

February 14, 2017

  Life Sciences Jobs   …
Source: BioSpace

Posted in BioPharma